Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.74 |
| ▸ | F2 | P00734 | 8/20 | 0.74 |
| ▸ | PLG | P00747 | 1/20 | 0.68 |
| ▸ | PROC | P04070 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL2329357 | 0.92 | F10 (0.88) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL2331992 | 0.92 | F10 (0.88) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL2331599 | 0.92 | F10 (0.89) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL2328799 | 0.90 | F10 (0.89) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL2334002 | 0.89 | F10 (0.88) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL1188533 | 0.89 | F10 (0.87) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL2329734 | 0.88 | F10 (0.90) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL2329087 | 0.87 | F10 (0.70) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL2328739 | 0.87 | F10 (0.89) | F10F2PLGPROC | |
| Trifluoroacetic Acid SCHEMBL2324863 | 0.87 | F10 (0.89) | F10F2PLGPROC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1363668-B1 | COMBINATIONS OF BILE ACID SEQUESTRANT(S) AND STEROL ABSORPTION INHIBITOR(S) AND TREATMENTS FOR VASCULAR INDICATIONS | SCHERING CORP (US) | 2007-08-15 | — | — | EP | claimed |
| EP-0853618-B1 | SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL -AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2011-08-17 | — | — | EP | disclosed |
| US-7897601-B2 | Cannabinoid receptor modulators | INTERVET, INC. (US) | 2011-03-01 | — | — | US | disclosed |
| US-7884080-B2 | Administering an azetidinone compound for treating a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease; T-type calcium channel blocking agent, an antagonist of TRPV1, an agonist of TRPV1, of GPR119, antagonist of NPCL1 | SCHERING PLOUGH CORPORATION (US) | 2011-02-08 | — | — | US | disclosed |